Treatment Strategies for Tardive Dyskinesia
US Pharm. 2025;50(5):HS2-HS5. ABSTRACT: Tardive dyskinesia (TD) is a potentially permanent neurologic disorder that is primarily associated with dopamine receptor antagonists, most commonly antipsychotics. Quality of life may be significantly affected in …